Lipoicmethylenedioxyphenol Reduces Experimental Atherosclerosis through Activation of Nrf2 Signaling.
OBJECTIVE:Oxidative stress is implicated in the pathogenesis of atherosclerosis, and Nrf2 is the transcriptional factor central in cellular antioxidant responses. In the present study, we investigate the effect of a dihydrolipoic acid derivative lipoicmethylenedioxyphenol (LMDP) on the progression o...
Main Authors: | Zhekang Ying, Minjie Chen, Xiaoyun Xie, Xiaoke Wang, Nisharahmed Kherada, Rajagopal Desikan, Georgeta Mihai, Patrick Burns, Qinghua Sun, Sanjay Rajagopalan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4747573?pdf=render |
Similar Items
-
Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.
by: Cuiqing Liu, et al.
Published: (2012-01-01) -
Modified methylenedioxyphenol analogs lower LDL cholesterol through induction of LDL receptor expression
by: Zhekang Ying, et al.
Published: (2012-05-01) -
Gadolinium-containing phosphatidylserine liposomes for molecular imaging of atherosclerosis
by: Andrei Maiseyeu, et al.
Published: (2009-11-01) -
The Beneficial Role of Nrf2 in the Endothelial Dysfunction of Atherosclerosis
by: Zixia Huang, et al.
Published: (2022-01-01) -
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis.
by: Freigang, S, et al.
Published: (2011)